ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 13
- 13F valueReported value at the end of Q2 2026
- $149.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding FEED, Q2 2026
No superinvestor reported holding FEED at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ENvue Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 22 | Same day | Glibert Christian MichaelOther: No longer subject to section 1 | SSale | −210.0K | $0.69 | −$144.9K | −100.0%0 after | |
| Feb 11, 2026 (view filing) | Jan 14 | 28 daysLate | Glibert Christian Michael10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +240.0K | $2.67 | +$640.8K | New position240.0K after | |
| Feb 4, 2026 (view filing)9:03 PM ET | Feb 2 | 2 days | Bank Of America Corp and 2 others10% Owner | SSale | −2.92K | $3.05 | −$8.91K | −1.2%231.1K after | 30 lots |
| Jan 5, 2023 (view filing)4:05 PM ET | Jan 5 | Same day | Mika ThomasDirector | PPurchase | +50.0K | $0.25 | +$12.5K | New position50.0K after | |
| Jun 17, 2022 (view filing) | Jun 15 | 2 days | Fashek Christopher MDirector | PPurchase | +40.0K | $0.60 | +$24.0K | +114.3%75.0K after | |
| Jun 17, 2022 (view filing) | Nov 20, 2019 | 940 daysLate | Fashek Christopher MDirector | PPurchase | +25.0K | $2.00 | +$50.0K | New position25.0K after | |
| Jun 14, 2022 (view filing) | Jun 14 | Same day | Brown Stephen RussellChief Financial Officer | PPurchase | +4.00K | $0.57 | +$2.28K | New position4.00K after | |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | Cassirer AuroraDirector | PPurchase | +2.00K | $0.69 | +$1.38K | New position2.00K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in ENvue Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 115,579 | $59.0K | 0.00% | +115,579 | New |
| Virtu Financial LLC | 95,296 | $49.0K | 0.00% | +95,296 | New |
| Jane Street Group, LLC | 37,635 | $19.4K | 0.00% | +37,635 | New |
| Geode Capital Management, LLC | 15,466 | $7.96K | 0.00% | −6,951−31.0% | Reduced |
| Two Sigma Securities, LLC | 10,279 | $5.29K | 0.00% | +10,279 | New |
| Advisor Group Holdings, Inc. | 10,000 | $5.15K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,781 | $2.46K | 0.00% | +1,962+69.6% | Added |
| Global Retirement Partners, LLC | 1,600 | $824 | 0.00% | +1,600 | New |
| Vanguard Capital Management LLC | 189 | $97 | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 85 | $44 | 0.00% | 00.0% | Unchanged |